AETHLON MEDICAL INC (AEMD)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

6.05 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2024, ended 31 Mar 2024, as filed

Revenue

$0.00

Net income

$12.21M

Free cash flow

$10.38M

Return on equity

-211.7%

Return on capital

-173.1%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
17 Dec 2020	Shah Chetan Director	Sold, plan not stated	$56.58K	61.7%
13 Apr 2010	BROENNIMAN EDWARD G Director	Sold, plan not stated	$1.64K	1.7%
12 Apr 2010	BROENNIMAN EDWARD G Director	Sold, plan not stated	$4.19K	4.2%
9 Apr 2010	BROENNIMAN EDWARD G Director	Sold, plan not stated	$4.15K	4.0%
8 Apr 2010	BROENNIMAN EDWARD G Director	Sold, plan not stated	$4.19K	3.9%
7 Apr 2010	BROENNIMAN EDWARD G Director	Sold, plan not stated	$4.20K	3.6%

37out of 100

Profitability 33

Financial strength 67

Growth 0

Insiders 50

Strongest on financial strength (67), weakest on growth (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan